Anti-IL17A重组抗体|科研级 Bimekizumab ( 比美吉珠单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-IL17A重组抗体|科研级 Bimekizumab ( 比美吉珠单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-IL17A重组抗体|科研级 Bimekizumab ( 比美吉珠单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1328

Alias

科研级 Bimekizumab ( 比美吉珠单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Bimekizumab

Molecular Name

Bimekizumab

Size

1mg, 5mg

CAS Number

1418205-77-2

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

ELISA, FC, IP, FuncS, IF, Neut

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

IL17A[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Bimekizumab (INN) is a humanized anti-IL17A and IL-17F monoclonal antibody that is being investigated for ankylosing spondylitis, psoriatic arthritis, and psoriasis. This drug is being developed by Belgian pharmaceutical UCB. As of 2018, bimekizumab is undergoing Phase III trials.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ